Adar1 Capital Management, LLC Bridge Bio Pharma, Inc. Call Options Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding BBIO
# of Institutions
295Shares Held
176MCall Options Held
8.64MPut Options Held
2.81M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$739 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$597 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$296 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$144 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.53B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...